Paclitaxel/carboplatin/etoposide (PCE) therapy for advanced poorly differentiated neuroendocrine (PDNE) carcinoma: A Minnie Pearl Cancer Research Network phase II trial.

被引：0
|
作者：
Miranda, FT
Spigel, DR
Hainsworth, JD
Thompson, DS
Yardley, DA
Burris, HA
Litchy, S
Shrader, M
Hon, JK
Corso, SW
Greco, FA
机构：
[1] Sarah Cannon Res Inst Tennessee, Nashville, TN USA
[2] Comprehens Canc Inst, Huntsville, AL USA
[3] Upstate Carolina CCOP, Spartanburg, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：322S / 322S
页数：1
相关论文
共 50 条
  • [1] Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: A Minnie Pearl Cancer Research Network Study
    Hainsworth, John D.
    Spigel, David R.
    Litchy, Sharlene
    Greco, F. Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) : 3548 - 3554
  • [2] Paclitaxel, carboplatin, and oral etoposide as initial treatment for advanced ovarian carcinoma: a Minnie Pearl Cancer Research Network phase II trial
    Hainsworth, JD
    Kalman, L
    Castine, M
    Sylvester, L
    Greco, FA
    GYNECOLOGIC ONCOLOGY, 2005, 97 (01) : 200 - 205
  • [3] Paclitaxel, carboplatin, and etoposide (TCE) in advanced poorly differentiated neuroendocrine carcinoma
    Loeffler, Luisa Mantovani
    Mauersberger, Elias
    Weimann, Arved
    Kuerschner, Dorit
    Schimmelpfennig, Christoph
    Wiechmann, Volker
    Bisanz, Heike
    Zeissig, Gisela
    Zeynalova, Samira
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive stage small cell lung cancer: A Minnie Pearl Cancer Research Network randomized prospective phase II trial.
    Thompson, DS
    Hainsworth, JD
    Morrissey, LH
    Erland, JB
    Burris, HA
    Joseph, G
    Corso, SW
    Spremulli, E
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
  • [5] Carcinoma of unknown primary site: Sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: A Minnie Pearl Cancer Research Network Phase II Trial
    Greco, FA
    Rodriguez, GI
    Shaffer, DW
    Hermann, R
    Litchy, S
    Yardley, DA
    Burris, HA
    Morrissey, LH
    Erland, JB
    Hainsworth, JD
    ONCOLOGIST, 2004, 9 (06): : 644 - 652
  • [6] Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    Litchy, S
    Schnell, FM
    Bearden, JD
    Yost, K
    Greco, FA
    CANCER, 2005, 103 (11) : 2298 - 2303
  • [7] Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung carcinoma - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Morrissey, LH
    Scullin, DC
    Houston, GA
    Prasthofer, EF
    Gray, JR
    Burris, HA
    Greco, FA
    CANCER, 2002, 94 (09) : 2426 - 2433
  • [8] Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Burris, HA
    Morrissey, LH
    Thomas, M
    Erland, JB
    Butts, JA
    Joseph, G
    Kalman, L
    Greco, FA
    CANCER JOURNAL, 2000, 6 (03): : 151 - 156
  • [9] Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: A minnie pearl cancer research network randomized, prospective phase II trial
    Greco, FA
    Thompson, DS
    Morrissey, LH
    Erland, JB
    Burris, HA
    Spigel, DR
    Joseph, G
    Corso, SW
    Spremulli, E
    Hainsworth, JD
    ONCOLOGIST, 2005, 10 (09): : 728 - 733
  • [10] Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: A phase II trial of the Minnie Pearl Cancer Research Network
    Meluch, AA
    Greco, FA
    Burris, HA
    O'Rourke, T
    Ortega, G
    Steis, RG
    Morrissey, LH
    Johnson, V
    Hainsworth, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3018 - 3024
12345